Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for seniors and people w ...
ARLINGTON, VIRGINIA / ACCESS Newswire / January 22, 2025 / The Centers for Medicare & Medicaid Services (CMS) has announced ...
The rescinded order directed Medicare and Medicaid to test ways to lower drug costs for enrollees. Those tests hadn’t started ...
Meena Seshamani’s Medicare swan song ended on a note of bravura: the announcement that 15 costly drugs, including Novo ...
The Department of Health and Human Services (HHS), through the Centers for Medicare & Medicaid Services (CMS), announced that 15 new drugs that are currently covered under Medicare Part D will be ...
Abe Sutton, a health policy aide in the first Trump administration, is likely to be named head of the Center for Medicare and ...
The Biden Administration announced the next batch of 15 prescription drugs that will be included in price negotiations with companies — with the aim of lowering costs for people covered by Medicare.
On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in ...
Ozempic and Wegovy, Novo Nordisk’s GLP-1 drugs that treat diabetes and obesity, are on the list. Astellas Pharma’s prostate cancer drug, Xtandi, is also on the list — alongside AstraZeneca’s cancer ...
The blockbuster diabetes and weight-loss drug semaglutide (Ozempic, Rybelsus, Wegovy) along with therapies for asthma, ...
Lewiston, Maine-based St. Mary's Health System is suing HHS for allegedly unlawfully withholding Medicare payments from the cash-strapped system, Maine Public Radio reported Jan. 14.